A carregar...

Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

In vitro treatment of Nf2-deficient cells with epidermal growth factor receptor (EGFR) inhibitors can inhibit cellular proliferation. We retrospectively assessed the effect of erlotinib (150 mg daily) on eleven consecutive NF2 patients with progressive VS who were poor candidates for standard therap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Plotkin, Scott R., Halpin, Chris, McKenna, Michael J., Loeffler, Jay S., Batchelor, Tracy T., Barker, Fred G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030413/
https://ncbi.nlm.nih.gov/pubmed/20736812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAO.0b013e3181eb328a
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!